Related references
Note: Only part of the references are listed.Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer
Yingyan Han et al.
EPIGENETICS (2020)
Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration
Chaoliang Liao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases
Can Cheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Chemical Proteomic Profiling of Protein 4′-Phosphopantetheinylation in Mammalian Cells
Nan Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease
Xianwen Yuan et al.
JOURNAL OF PROTEOMICS (2020)
DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma
Xiangjian Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
Hsi-Hsien Hsu et al.
CANCERS (2019)
Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
Can Cheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Neutrophils: a cornerstone of liver ischemia and reperfusion injury
Thiago Henrique Caldeira de Oliveira et al.
LABORATORY INVESTIGATION (2018)
DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
Y. Zhou et al.
ONCOGENE (2018)
The prognostic value of HOXA13 in solid tumors: A meta-analysis
Yaoan Wen et al.
CLINICA CHIMICA ACTA (2018)
Screening for esophageal squamous cell carcinoma: recent advances
Don C. Codipilly et al.
GASTROINTESTINAL ENDOSCOPY (2018)
Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
Hsi-Hsien Hsu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway
Yang Han et al.
MOLECULAR CARCINOGENESIS (2018)
Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond
Hailin Zhao et al.
EBIOMEDICINE (2018)
Dendritic cells as gatekeepers of tolerance
Ari Waisman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Emerging roles of lipid metabolism in cancer metastasis
Xiangjian Luo et al.
MOLECULAR CANCER (2017)
Progress in the treatment of advanced gastric cancer
Zheyu Song et al.
TUMOR BIOLOGY (2017)
Primary and secondary prevention of breast cancer
Agnieszka Kolak et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2017)
Formas hereditarias de cáncer colorrectal
Antoni Castells
Gastroenterologia y Hepatologia (2016)
Nasopharyngeal Cancer: Molecular Landscape
Jeff P. Bruce et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma
Z. -Z. Shi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Cardiovascular Disease in Survivors of Adolescent and Young Adult Cancer: A Danish Cohort Study, 1943-2009
Kathrine Rugbjerg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Lipid Metabolism Genes in Contralateral Unaffected Breast and Estrogen Receptor Status of Breast Cancer
Jun Wang et al.
CANCER PREVENTION RESEARCH (2013)
Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells
Stefanie Kewitz et al.
PLOS ONE (2013)
MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors
Wajana L. Labisso et al.
CELL CYCLE (2012)
Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes
Franco Gabrielli et al.
GENE (2012)
Glucose reintroduction triggers the activation of Nrf2 during experimental ischemia reperfusion
Daniel Crean et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches
Kwok-Wai Lo et al.
SEMINARS IN CANCER BIOLOGY (2012)
Recent Progress in the Diagnosis and Treatment of Ovarian Cancer
Danijela Jelovac et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Depsipeptide-resistant KU812 cells show reversible P-glycoprotein expression, hyper-acetylated histones, and modulated gene expression profile
H Yamada et al.
LEUKEMIA RESEARCH (2006)
Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue
N Shafqat et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
A human short-chain dehydrogenase/reductase gene: structure, chromosomal localization, tissue expression and subcellular localization of its product
S Pellegrini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Genomic organization of the human gene HEP27:: Alternative promoter usage in HepG2 cells and monocyte-derived dendritic cells
S Heinz et al.
GENOMICS (2002)